KR19990036137A - 암 성장을 억제하기 위한 그리세오풀빈의 용도 - Google Patents

암 성장을 억제하기 위한 그리세오풀빈의 용도 Download PDF

Info

Publication number
KR19990036137A
KR19990036137A KR1019980700805A KR19980700805A KR19990036137A KR 19990036137 A KR19990036137 A KR 19990036137A KR 1019980700805 A KR1019980700805 A KR 1019980700805A KR 19980700805 A KR19980700805 A KR 19980700805A KR 19990036137 A KR19990036137 A KR 19990036137A
Authority
KR
South Korea
Prior art keywords
griseofulvin
cancer
agents
tumors
pharmaceutical composition
Prior art date
Application number
KR1019980700805A
Other languages
English (en)
Korean (ko)
Inventor
제임스 버거 캄든
Original Assignee
데이비드 엠 모이어
더 프록터 앤드 갬블 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데이비드 엠 모이어, 더 프록터 앤드 갬블 캄파니 filed Critical 데이비드 엠 모이어
Publication of KR19990036137A publication Critical patent/KR19990036137A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019980700805A 1995-08-03 1996-07-30 암 성장을 억제하기 위한 그리세오풀빈의 용도 KR19990036137A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US183995P 1995-08-03 1995-08-03
US60/001839 1995-08-03
US67418196A 1996-07-16 1996-07-16
US8/674,181 1996-07-16
US8/674181 1996-07-16

Publications (1)

Publication Number Publication Date
KR19990036137A true KR19990036137A (ko) 1999-05-25

Family

ID=26669547

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980700805A KR19990036137A (ko) 1995-08-03 1996-07-30 암 성장을 억제하기 위한 그리세오풀빈의 용도

Country Status (16)

Country Link
EP (1) EP0841914A2 (es)
JP (1) JPH11511136A (es)
KR (1) KR19990036137A (es)
AR (1) AR003176A1 (es)
AU (1) AU713031B2 (es)
BR (1) BR9609920A (es)
CA (1) CA2228503A1 (es)
CZ (1) CZ30598A3 (es)
HU (1) HUP9903506A3 (es)
IL (1) IL123094A0 (es)
MX (1) MX9800945A (es)
NO (1) NO980420L (es)
PL (1) PL324905A1 (es)
SK (1) SK14298A3 (es)
TR (1) TR199800244T2 (es)
WO (1) WO1997005870A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
DK1098641T3 (en) * 1998-07-27 2016-08-15 St Jude Pharmaceuticals Inc Chemically induced intracellular hyperthermia
AU761844C (en) 1998-11-09 2004-09-23 F. Hoffmann-La Roche Ag Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
CN1543356B (zh) * 2001-06-25 2011-09-28 味之素株式会社 抗肿瘤剂
EP2008652A1 (en) * 2007-06-28 2008-12-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
EP2204367A1 (en) 2008-12-22 2010-07-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Also Published As

Publication number Publication date
AU6683496A (en) 1997-03-05
SK14298A3 (en) 1998-09-09
HUP9903506A2 (hu) 2000-06-28
IL123094A0 (en) 1998-09-24
AU713031B2 (en) 1999-11-18
NO980420L (no) 1998-04-03
CA2228503A1 (en) 1997-02-20
TR199800244T2 (xx) 1998-09-21
NO980420D0 (no) 1998-01-30
WO1997005870A2 (en) 1997-02-20
MX9800945A (es) 1998-04-30
AR003176A1 (es) 1998-07-08
EP0841914A2 (en) 1998-05-20
HUP9903506A3 (en) 2000-07-28
PL324905A1 (en) 1998-06-22
BR9609920A (pt) 1999-07-06
JPH11511136A (ja) 1999-09-28
CZ30598A3 (cs) 1998-06-17
WO1997005870A3 (en) 1997-04-17

Similar Documents

Publication Publication Date Title
KR19990036137A (ko) 암 성장을 억제하기 위한 그리세오풀빈의 용도
KR20000049065A (ko) 바이러스성 감염증 및 암 치료용 벤즈이미다졸-2-카르바메이트
KR19990036138A (ko) 암 성장을 억제하기 위한 플루코나졸의 용도
JP2007284446A (ja) 癌増殖を阻止するベンゾイミダゾール含有医薬組成物
MXPA98000945A (es) Uso de griseofulvina para inhibir el crecimientode canceres
KR20000070551A (ko) 화학 요법제 및 벤즈이미다졸, 및 선택적으로 강화제를 함유하는 암세포 성장 억제용 키트
MXPA98000998A (es) Uso de fluconazol para inhibir el crecimiento de canceres
KR20000049064A (ko) Ｈｉｖ 및 암 치료제
CZ323897A3 (cs) Farmaceutický prostředek pro léčbu rakovin, nádorů a virových infekcí
KR19990036136A (ko) 암 성장을 억제하기 위한 1ｈ-1,2,4-트리아졸 유도체의 용도
RU2170577C2 (ru) Фармацевтическая композиция, содержащая n-хлорфенилкарбамат или n-хлорфенилтиокарбамат, композиция стандартной лекарственной формы и способ лечения рака
JP2003528920A (ja) 血管損傷性活性を有する併用療法
MXPA97007809A (es) Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres
US5908855A (en) Compositions for treating viral infections
MXPA98000944A (es) Uso de derivados de 1h-1,2,4-triazol para inhibirel crecimiento de canceres
US20010041678A1 (en) Compositions and methods for treating cancer
MXPA97007808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres
DE60011060T2 (de) Virus behandlung
MXPA97007810A (es) Una composicion farmaceutica que contiene derivados de n-fosfonoglicina para inhibir el crecimientode virus y canceres

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
A107 Divisional application of patent
E902 Notification of reason for refusal
E601 Decision to refuse application